EBMT 2019 | Patient advocacy in the treatment journey
Anita Waldmann, of Leukaemia Patient-Support Group RHEIN-MAIN, Ruesselsheim am Main, Germany, talks about how patient advocacy groups are useful tools for patients in the cancer treatment journey. Ms Waldmann mentions how they bring to the table a new aspect, patient input, regarding novel therapies, in order to help HCPs appreciate the patient’s point of view. Recorded at the European Society for Blood and Marrow Transplantation (EBMT) 2019 Annual Meeting, held in Frankfurt, Germany.
Get great new content delivered to your inboxSign up